世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヒト絨毛性ゴナドトロピン（HCG）市場：技術（天然源抽出、遺伝子組換え技術）、治療領域（女性不妊治療、男性性腺機能低下症、寡精症治療、その他）、エンドユーザー（不妊クリニック、研究機関、その他）、地域別 2023-2028


Human Chorionic Gonadotropin (HCG) Market by Technology (Natural Source Extraction, Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), End User (Fertility Clinics, Research Institutions, and Others), and Region 2023-2028

市場の概要 世界のヒト絨毛性ゴナドトロピン（HCG）市場規模は、2022年に903.78Million米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.62%の成長率（CAGR）を示し、2028年までに1,411.06 ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		143 英語

　

サマリー

市場の概要

世界のヒト絨毛性ゴナドトロピン（HCG）市場規模は、2022年に903.78Million米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.62%の成長率（CAGR）を示し、2028年までに1,411.06 Million米ドルに達すると予測しています。女性の不妊症の増加、性腺機能低下症関連疾患の増加、組換え技術を用いたHCGの生産などが、市場を牽引する主な要因の一つです。

ヒト絨毛性ゴナドトロピン（HCG）は、妊娠中に胎盤の滑膜栄養芽球細胞から産生される化学物質です。血液、尿、肝臓、結腸、下垂体などに含まれる。HCGは黄体を刺激してプロゲステロンを分泌させ、妊娠を維持します。イオン交換クロマトグラフィー、色素親和性クロマトグラフィー、ナノフィルトレーション、逆相高速液体クロマトグラフィー（HPLC）などの様々な手法を用いて、臨床応用のために妊婦の尿から抽出・精製されます。HCGは、不妊症の治療、妊娠の可能性の向上、テストステロンと精子の生成の補助、男性小児の陰睾の治療などに広く使用されています。また、妊娠関連疾患、出生前スクリーニング、婦人科系癌の診断やモニタリングにも役立っています。

ヒト絨毛性ゴナドトロピン（HCG）市場動向：

子宮疾患、卵管閉塞、多嚢胞性卵巣症候群（PCOS）、内分泌系疾患などによる女性の不妊症の増加などが、市場成長を促す主な要因となっています。HCGは、排卵誘発の補助、胚の形成促進、卵子採取の正しいタイミングの促進、子宮内膜の厚さの増加、子宮内膜受容性の改善などの効果があるため、体外受精（IVF）や子宮内人工授精（IUI）など、女性不妊症を治療するさまざまな生殖補助技術に広く使用されています。また、他の排卵誘発剤と併用することで、女性の妊娠の可能性を高めることができることも、成長を促進する要因となっています。さらに、肥満や2型糖尿病を患う男性における性腺機能低下症関連疾患の有病率の増加に伴い、テストステロン値の改善、生殖能力の強化、性機能の促進を目的としたHCGの適用が増加していることも、市場の成長を後押ししています。さらに、天然由来のHCGと比較して、同一の特性、強化された有効性、および改善された安全性を提供し、患者の耐性を高める組換え技術を用いたHCGの生産は、市場の成長にプラスの影響を及ぼしています。その他、医療インフラの急速な発展、不妊症に関する治療やサービスの増加、老人人口の増加、新しい精製・抽出技術の発売のための広範な研究開発活動、人々の性的健康を改善するためのさまざまな政府の取り組みの実施などが、市場の成長をさらに促進すると予想されます。

主要な市場セグメント：

IMARC Groupは、世界のヒト絨毛性ゴナドトロピン（HCG）市場の各セグメントにおける主要動向の分析、および2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、市場を技術、治療分野、エンドユーザーに基づいて分類しています。

テクノロジーインサイト

天然由来成分抽出
リコンビナントテクノロジー


また、ヒト絨毛性ゴナドトロピン（HCG）市場について、技術に基づく詳細な分解・分析も行っています。これには、天然源抽出と組換え技術が含まれます。それによると、天然源抽出が最大のセグメントを占めています。

治療領域の洞察：

女性不妊治療
男性性腺機能低下症（Hypogonadism
オリゴ糖の治療
その他


本レポートでは、ヒト絨毛性ゴナドトロピン（HCG）市場を治療分野別に詳細に分類・分析しています。これには、女性不妊治療、男性性腺機能低下症、乏精子症治療、およびその他が含まれます。それによると、女性不妊治療が最大の市場シェアを占めています。

エンドユーザーのインサイト：

妊産婦のためのクリニック
研究機関
その他


ヒト絨毛性ゴナドトロピン（HCG）市場をエンドユーザー別に詳細に分解・分析した報告書を掲載しました。これには、不妊治療クリニック、研究機関、その他が含まれます。それによると、不妊治療クリニックが最大の市場シェアを占めています。

地域別インサイト

北アメリカ

ユーエスエー
カナダ


ヨーロッパ

ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他


アジア太平洋

中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他


ラテンアメリカ

ブラジル
メキシコ
その他


中近東・アフリカ


また、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、中南米（ブラジル、メキシコ、その他）、中東・アフリカを含むすべての主要地域市場について包括的に分析を行っています。それによると、ヒト絨毛性ゴナドトロピン（HCG）の市場は、北米が最大であった。北米のヒト絨毛性ゴナドトロピン（HCG）市場を牽引する要因としては、女性の不妊症の増加、不妊症や婦人科系疾患の治療法に関する消費者の意識の高まり、消費者の支出能力の上昇などが挙げられます。

競合の状況：

また、世界のヒト絨毛性ゴナドトロピン（HCG）市場における競争環境についても包括的に分析しています。また、すべての主要企業の詳細なプロファイルも提供しています。対象となる企業には、Biocare Medical LLC、Ferring Pharmaceuticals、Fresenius SE & Co.KGaA、神谷バイオメディカル株式会社（日東紡績株式会社）、Lee Biosolutions Inc.（Oy Medix Biochemica Ab）、Merck & Co.Inc.、Prospec-Tany Technogene Ltd.、Scripps Laboratories Inc.、Sun Pharmaceutical Industries Limited など。なお、これは企業の一部のリストであり、完全なリストは報告書で提供されています。

本レポートで回答した主な質問
世界のヒト絨毛性ゴナドトロピン（HCG）市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
世界のヒト絨毛性ゴナドトロピン（HCG）市場における推進要因、阻害要因、機会は何か？
主要な地域市場とは？
最も魅力的なヒト絨毛性ゴナドトロピン（HCG）市場はどの国か？
技術に基づく市場の内訳は？
治療分野別の市場構成は？
エンドユーザーに基づく市場のブレークアップは？
世界のヒト絨毛性ゴナドトロピン（HCG）市場の競争構造は？
世界のヒト絨毛性ゴナドトロピン（HCG）市場における主要プレイヤー/企業は？

ページTOPに戻る


目次

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Human Chorionic Gonadotropin (HCG) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technology
    6.1    Natural Source Extraction
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Recombinant Technology
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Therapeutic Area
    7.1    Female Infertility Treatment
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Male Hypogonadism
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Oligospermic Treatment
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by End User
    8.1    Fertility Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research Institutions
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Biocare Medical LLC
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Ferring Pharmaceuticals
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Fresenius SE & Co. KGaA
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Kamiya Biomedical Company (Nitto Boseki Co. Ltd.)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Lee Biosolutions Inc. (Oy Medix Biochemica Ab)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Prospec-Tany Technogene Ltd.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Scripps Laboratories Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Sun Pharmaceutical Industries Limited
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Human Chorionic Gonadotropin Market: Major Drivers and Challenges
Figure 2: Global: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Human Chorionic Gonadotropin Market: Breakup by Technology (in %), 2022
Figure 5: Global: Human Chorionic Gonadotropin Market: Breakup by Therapeutic Area (in %), 2022
Figure 6: Global: Human Chorionic Gonadotropin Market: Breakup by End User (in %), 2022
Figure 7: Global: Human Chorionic Gonadotropin Market: Breakup by Region (in %), 2022
Figure 8: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Human Chorionic Gonadotropin (Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Human Chorionic Gonadotropin (Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Human Chorionic Gonadotropin (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Human Chorionic Gonadotropin (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Human Chorionic Gonadotropin Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Human Chorionic Gonadotropin Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Human Chorionic Gonadotropin Industry: Value Chain Analysis
Figure 77: Global: Human Chorionic Gonadotropin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Human Chorionic Gonadotropin Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 3: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 4: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Human Chorionic Gonadotropin Market: Competitive Structure
Table 7: Global: Human Chorionic Gonadotropin Market: Key Players

　

ページTOPに戻る


　

Summary

Market Overview:

The global human chorionic gonadotropin (HCG) market size reached US$ 903.78 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,411.06 Million by 2028, exhibiting a growth rate (CAGR) of 7.62% during 2023-2028. The rising incidences of infertility in women, increasing prevalence of hypogonadism-related disorders, and production of HCG using recombinant technology represent some of the key factors driving the market.

Human chorionic gonadotropin (HCG) is a chemical produced by syncytiotrophoblastic cells of the placenta during pregnancy. It is found in blood, urine, liver, colon, and pituitary glands. HCG stimulates the corpus luteum to produce progesterone to maintain the pregnancy. It is extracted and purified from the urine of pregnant women for clinical applications using various techniques, such as ion exchange chromatography, dye-affinity chromatography, nanofiltration, and reverse-phase high-performance liquid chromatography (HPLC). HCG is widely used to treat infertility, increase the chances of pregnancy, help in the production of testosterone and sperm, and treat cryptorchidism in male children. It also aids in diagnosing and monitoring pregnancy-related disorders, prenatal screening, and gynecological cancers.

Human Chorionic Gonadotropin (HCG) Market Trends:

The rising incidences of infertility among females due to uterine disorders, blocked fallopian tube, polycystic ovarian syndrome (PCOS), and endocrine system disorders are among the key factors driving the market growth. HCG is widely used in various assisted reproductive technologies, such as in-vitro fertilization (IVF) and intrauterine insemination (IUI), to treat female infertility, as it aids in inducing ovulation, promotes the formation of the embryo, facilitates correct timing of oocyte retrieval, increases endometrial thickness, and improve endometrial receptivity. In addition to this, the widespread product utilization in combination with other fertility drugs to increase the chances of pregnancy in women is acting as another growth-inducing factor. Furthermore, the increasing application of HCG to improve testosterone levels, enhance fertility, and promote sexual function due to the increasing prevalence of hypogonadism-related disorders in males suffering from obesity and type 2 diabetes is favoring the market growth. Additionally, the production of HCG using recombinant technology that provides identical properties, enhanced efficacy, and improved safety compared to naturally sourced HCG and enhances patient tolerance is positively influencing the market growth. Other factors, including the rapid development of healthcare infrastructure, increasing availability of treatment and services regarding infertility, rising geriatric population, extensive research and development (R&D) activities for the launch of novel purification and extraction technologies, and the implementation of various government initiatives to improve the sexual health of people, are anticipated to drive the market growth further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global human chorionic gonadotropin (HCG) market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on technology, therapeutic area, and end user.

Technology Insights:

Natural Source Extraction
Recombinant Technology


The report has also provided a detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the technology. This includes natural source extraction and recombinant technology. According to the report, natural source extraction represented the largest segment.

Therapeutic Area Insights:

Female Infertility Treatment
Male Hypogonadism
Oligospermic Treatment
Others


A detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the therapeutic area has been provided in the report. This includes female infertility treatment, male hypogonadism, oligospermic treatment, and others. According to the report, female infertility treatment accounted for the largest market share.

End User Insights:

Fertility Clinics
Research Institutions
Others


A detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the end user has been provided in the report. This includes fertility clinics, research institutions, and others. According to the report, fertility clinics accounted for the largest market share.

Regional Insights:

North America

United States
Canada


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa


The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for human chorionic gonadotropin (HCG). Some of the factors driving the North America human chorionic gonadotropin (HCG) market include rising incidences of infertility among women, growing consumer awareness regarding the available treatment for infertility and gynecological concerns, and rising expenditure capacities of consumers.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global human chorionic gonadotropin (HCG) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Biocare Medical LLC, Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Kamiya Biomedical Company (Nitto Boseki Co. Ltd.), Lee Biosolutions Inc. (Oy Medix Biochemica Ab), Merck & Co. Inc., Prospec-Tany Technogene Ltd., Scripps Laboratories Inc., Sun Pharmaceutical Industries Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global human chorionic gonadotropin (HCG) market performed so far and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global human chorionic gonadotropin (HCG) market?
What are the key regional markets?
Which countries represent the most attractive human chorionic gonadotropin (HCG) markets?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the therapeutic area?
What is the breakup of the market based on the end user?
What is the competitive structure of the global human chorionic gonadotropin (HCG) market?
Who are the key players/companies in the global human chorionic gonadotropin (HCG) market?



ページTOPに戻る


Table of Contents

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Human Chorionic Gonadotropin (HCG) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technology
    6.1    Natural Source Extraction
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Recombinant Technology
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Therapeutic Area
    7.1    Female Infertility Treatment
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Male Hypogonadism
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Oligospermic Treatment
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by End User
    8.1    Fertility Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Research Institutions
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    Drivers, Restraints, and Opportunities
    10.1    Overview
    10.2    Drivers
    10.3    Restraints
    10.4    Opportunities
11    Value Chain Analysis
12    Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Biocare Medical LLC
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Ferring Pharmaceuticals
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Fresenius SE & Co. KGaA
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Kamiya Biomedical Company (Nitto Boseki Co. Ltd.)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Lee Biosolutions Inc. (Oy Medix Biochemica Ab)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Merck & Co. Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Prospec-Tany Technogene Ltd.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Scripps Laboratories Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Sun Pharmaceutical Industries Limited
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Human Chorionic Gonadotropin Market: Major Drivers and Challenges
Figure 2: Global: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Human Chorionic Gonadotropin Market: Breakup by Technology (in %), 2022
Figure 5: Global: Human Chorionic Gonadotropin Market: Breakup by Therapeutic Area (in %), 2022
Figure 6: Global: Human Chorionic Gonadotropin Market: Breakup by End User (in %), 2022
Figure 7: Global: Human Chorionic Gonadotropin Market: Breakup by Region (in %), 2022
Figure 8: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Human Chorionic Gonadotropin (Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Human Chorionic Gonadotropin (Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Human Chorionic Gonadotropin (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Human Chorionic Gonadotropin (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: North America: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: North America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: United States: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: United States: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Canada: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Canada: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Asia-Pacific: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Asia-Pacific: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: China: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: China: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Japan: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Japan: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: India: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: India: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: South Korea: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: South Korea: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Australia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Australia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Indonesia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Indonesia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Europe: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Europe: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Germany: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Germany: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: France: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: France: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United Kingdom: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United Kingdom: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Italy: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Italy: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Spain: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Spain: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Russia: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Russia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Latin America: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Latin America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Brazil: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Brazil: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Mexico: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Mexico: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Middle East and Africa: Human Chorionic Gonadotropin Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Middle East and Africa: Human Chorionic Gonadotropin Market: Breakup by Country (in %), 2022
Figure 74: Middle East and Africa: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Global: Human Chorionic Gonadotropin Industry: Drivers, Restraints, and Opportunities
Figure 76: Global: Human Chorionic Gonadotropin Industry: Value Chain Analysis
Figure 77: Global: Human Chorionic Gonadotropin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Human Chorionic Gonadotropin Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 3: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 4: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Human Chorionic Gonadotropin Market: Competitive Structure
Table 7: Global: Human Chorionic Gonadotropin Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

IMARC Services Private Limited. 社の最新刊レポート

本レポートと同じKEY WORD（chorionic gonadotropin）の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19　10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.